Clinical Trial: Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07641361) titled 'Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy' on March 25.

Brief Summary: This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting to assess feasibility and preliminary efficacy of the intervention through examining participant retention, participant feedbac...